Emerald Health Therapeutics
Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (Emerald) is a Health Canada Licensed Producer of medical cannabis and is significantly expanding production capacity in anticipation of the legal adult-use cannabis market in Canada, slated for October 17, 2018. Emerald’s multi-phase expansion plan includes a joint venture of 1.1 million square feet with an additional 3.7 million square foot option, as well as 575K square feet in wholly owned, established/planned grow facilities. The vertically integrated, seed-to-sale enterprise combines core competencies in pharmaceutical innovation and large-scale agriculture. Our ambition is to be at the forefront of developing knowledge and products that provide wellness and health benefits from cannabis.